BioCentury

7:00 AM GMT, Nov 1, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Status

S/GSK1349572: Phase III started

Shionogi and ViiV Healthcare LLC, a JV between GlaxoSmithKline and Pfizer, began the double-blind, international Phase III

Read the full 174 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.